Press Releases OptimizeRx Corporation

Equities

OPRX

US68401U2042

Real-time Estimate Cboe BZX Other stock markets 01:03:45 14/05/2024 am IST			5-day change	1st Jan Change
10.52 ^USD	-2.64%		-1.13%	-26.62%

29/04	OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024	CI
16/04	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OptimizeRx to Participate in Upcoming Investor Conferences	07/05	AQ
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET	26/04	AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report	18/04	AQ
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results	16/04	AQ
OptimizeRx : ESG Report	12/04	PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row	11/04	AQ
OptimizeRx : Corporate Presentation	05/04	PU
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET	25/03	AQ
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023	12/03	AQ
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort	05/03	AQ
OptimizeRx to Participate in Upcoming Investor Conferences	21/02	AQ
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape	25/01	AQ
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update	09/01	AQ
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco	18/12	AQ
OptimizeRx Reports Third Quarter 2023 Financial Results	06/11	AQ
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET	25/23/25	AQ
OptimizeRx : Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be $0.6-$1 million - Form 8-K	17/23/17	PU
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers	12/23/12	AQ
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform	26/23/26	AQ
OptimizeRx Expands AI Powered Omnichannel Platform	24/23/24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OptimizeRx Corporation

Equities

OPRX

US68401U2042

Press Releases

Filters